Amarin

Ebitda Cambiamento Data
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amarin USD -7332000 8.44M 2023-09
AstraZeneca USD 3.43B 412M 2023-09
GlaxoSmithKline GBP 3.17B 729M 2023-09
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09



Amarin - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.